Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Ovarian Neoplasms

Free Subscription 06.04.2026 3 BMC Cancer 2 Cancer Lett 2 Cancer Res 1 Eur J Obstet Gynecol Reprod Biol 1 Gynecol Oncol 1 Int J Cancer 2 Oncogene 2 Oncol Rep 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. ARCH JJ, Uno H, Poort H, Slivjak E, et al
   Randomized clinical trial of an Acceptance and Commitment Therapy telehealth intervention ('REVITALIZE') to reduce fatigue interference in women with advanced ovarian cancer on PARP inhibitors: study protocol.
   BMC Cancer. 2026 Apr 2. doi: 10.1186/s12885-026-15936.
   PubMed        
   
   
2. LUJEA N, De Leon Rodriguez M, Chiola F, Acosta C, et al
   The physical properties of ascitic fluid enhance metastatic potential by inducing mitotic abnormalities and multinucleation in ovarian cancer.
   BMC Cancer. 2026 Apr 1. doi: 10.1186/s12885-026-15683.
   PubMed         Abstract available
   
   
3. FENG Y, Hu Y, Li T, Li M, et al
   XGBoost-Cox modeling with SHAP analysis for survival prediction in ovarian cancer patients: a retrospective cohort study.
   BMC Cancer. 2026 Mar 27. doi: 10.1186/s12885-026-15921.
   PubMed        
   
   

   
   Cancer Lett

4. GHOSH D, White B, Lu X, Perricone M, et al
   Autophagy is essential for survival and function of polyploid giant cancer cells under therapeutic stress.
   Cancer Lett. 2026;646:218431.
   PubMed         Abstract available
   
   
5. PANESSO-GOMEZ S, Cole AJ, Arrigo A, Roberts A, et al
   Identification of the MRTFA/SRF pathway as a critical regulator of quiescence and chemotherapy resistance in cancer.
   Cancer Lett. 2026;646:218435.
   PubMed         Abstract available
   
   

   
   Cancer Res

6. SOONG TR, Verma P, Nephew KP
   Not All STICs Are Equal: Unraveling the Implications of Precursor Heterogeneity.
   Cancer Res. 2026;86:1537-1539.
   PubMed         Abstract available
   
   
7. CHANG TY, Chien YW, Chen SH, Sokolow A, et al
   Integrated Spatial Analysis Reveals the Molecular Landscape of Ovarian Precancerous Lesions.
   Cancer Res. 2025 Dec 18. doi: 10.1158/0008-5472.CAN-25-3189.
   PubMed         Abstract available
   
   

   
   Eur J Obstet Gynecol Reprod Biol

8. FUKUDA K, Sakabe N, Sato S, Hara T, et al
   Classification of histological types in ovarian cancer using deep learning.
   Eur J Obstet Gynecol Reprod Biol. 2026;321:115080.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

9. SCHREUDER GOEDHEIJT M, Aronson SL, Sonke GS, van Driel WJ, et al
   Influence of cardiophrenic lymph nodes on survival in patients receiving hyperthermic intraperitoneal chemotherapy for ovarian cancer in the OVHIPEC-1 trial.
   Gynecol Oncol. 2026;208:54-62.
   PubMed         Abstract available
   
   

   
   Int J Cancer

10. JIANG M, Yamaguchi K, Hamada K, Hosoe Y, et al
    HIF2A as a prognostic and clinical therapeutic target in ovarian clear cell carcinoma.
    Int J Cancer. 2026 Jan 27. doi: 10.1002/ijc.70341.
    PubMed         Abstract available
    
    

    
    Oncogene

11. LOBERMEYER A, Schollhorn JS, Rademacher PN, Wankner MC, et al
    Pre-operative circulating tumor cells predict worse treatment outcome in patients with high-grade serous ovarian cancer.
    Oncogene. 2026 Apr 4. doi: 10.1038/s41388-026-03747.
    PubMed         Abstract available
    
    
12. PU Y, Chen Z, Gao Q, Liu Y, et al
    Spliceosomal component SNRPE drives cell proliferation by regulating CTP synthase 1 mRNA splicing in ovarian cancer.
    Oncogene. 2026 Apr 4. doi: 10.1038/s41388-026-03764.
    PubMed         Abstract available
    
    

    
    Oncol Rep

13. CHENG L, Zhang D, Yan W
    [Retracted] Ultrasound?targeted microbubble destruction?mediated overexpression of Sirtuin 3 inhibits the progression of ovarian cancer.
    Oncol Rep. 2026;55:105.
    PubMed         Abstract available
    
    
14. HAO X, Chen Y
    ZBTB7A promotes malignant phenotypes in ovarian cancer through transcriptional activation of CRLF1.
    Oncol Rep. 2026;55:102.
    PubMed         Abstract available
    
    

    
    PLoS One

15. KIM JY, Lee YK, Shin HY, Kim YJ, et al
    Biobanking of gynecologic cancer biospecimens: Development, quality control, and translational applications.
    PLoS One. 2026;21:e0345861.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum